Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Alpha Lipoic Acid 600 mg HR Tablets
NCT04214665Phase 1Completed
- Sponsor
- İlko İlaç
- Start
- Dec 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of alpha-lipoic acid in diabetic polyneuropathy (DPN) (2 arms), sponsored by İlko İlaç. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to Last Timepoint. Started Dec 2014; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT04214665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04214665.